cyc 202 has been researched along with corticosterone in 4 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (corticosterone) | Trials (corticosterone) | Recent Studies (post-2010) (corticosterone) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 27,121 | 124 | 6,622 |
| Protein | Taxonomy | cyc 202 (IC50) | corticosterone (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 3 | Homo sapiens (human) | 0.945 | |
| Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | 4.9 | |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 4.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Amin, ND; Chakrabarti, M; Chrousos, GP; Jaffe, H; Kino, T; Pant, HC; Zheng, YL | 1 |
| Ben-Shlomo, A; Fan, XM; Jiang, H; Lin, S; Liu, NA; Melmed, S; Wawrowsky, K | 1 |
4 other study(ies) available for cyc 202 and corticosterone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor.
Topics: Aldosterone; Animals; Blotting, Western; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Cells, Cultured; Corticosterone; Cyclin-Dependent Kinase 5; Dexamethasone; Humans; Immunoprecipitation; Mass Spectrometry; Phosphorylation; Polymerase Chain Reaction; Purines; Rats; Receptors, Mineralocorticoid; Roscovitine; Two-Hybrid System Techniques | 2010 |
Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor.
Topics: ACTH-Secreting Pituitary Adenoma; Adrenocorticotropic Hormone; Animals; Animals, Genetically Modified; Antineoplastic Agents; Corticosterone; Cyclin E; Cyclin-Dependent Kinases; Gene Expression Regulation; Mice; Pituitary ACTH Hypersecretion; Purines; Roscovitine; Zebrafish | 2011 |